Skip to primary navigation Skip to main content
0 item $0.00

This webinar, hosted by Baker Institute ambassador Matt Keenan features the Head of Preclinical Disease and Prevention Associate Professor Melinda Carrington.

They discuss what personalised medicine is and how it can revolutionise the way we predict and treat heart disease and diabetes.

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more